Real-time enrollment status for this glabellar lines clinical trial
Current Status
Recruiting
Checked: September 9, 2026 at 9:54 PM UTC
| NCT Number | NCT07756580 |
| Recruiting Status | Recruiting |
| Condition | Glabellar Lines |
| Phase | PHASE1 |
| Target Enrollment | 120 participants |
| Active Locations | 8 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | September 9, 2026 (21 hours ago) |
As of September 9, 2026: Clinical trial NCT07756580 is currently recruiting participants. This phase1 study for glabellar lines is actively seeking new participants at 8 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07756580 is actively recruiting participants as of September 9, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07756580 was last updated 21 hours ago (September 9, 2026). HelloStudys verifies this status automatically.